Moreover, MYD88 mutations frequently co-occur with CD79B mutations, defining the MCD (MYD88/CD79B) genetic subtype, which is predominantly observed in non-GCB DLBCL. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.